AF Management Think Forward in AF Management for Device Patients
At BIOTRONIK, we have been consistently prioritizing atrial fibrillation (AF) management in the development of our cardiac rhythm devices. Our mission is to lead the way in AF management for CIED patients, ensuring that every heartbeat is monitored, managed, and maintained with the utmost precision and care. Over time, we have generated extensive clinical evidence on our technologies across various therapy areas.
Our Vision is to create a future where AF is detected early, managed effectively, and monitored continuously, providing patients with the highest quality of life.
Think forward.
Preventing AF
Through Closed Loop Stimulation (CLS) within our Amvia pacemaker family we address AF progression effectively, aiming to reduce its impact on patients’ lives.
Detecting AF
With our unique DX Technology within our Acticor/Rivacor ICD family we ensure precise early detection to enable timely interventions.
Diagnosing AF
We thrive for workflow optimization with SmartECG - the AI solution within our BIOMONITOR IV - to efficiently diagnose AF and distinguish between true and false detections.
Managing AF
We improve workflow for physicians and quality of life for patients by managing device patients with Home Monitoring at the core providing real-time insights for quick and informed interventions, HeartInsight with algorithms to predict the heart failure risk and efficient management of stable atrial arrhythmias.
